General Information of Disease (ID: DIS1DPSN)

Disease Name Hurler syndrome
Synonyms mucopolysaccharidosis IH; MPS1-H; MPS1H; mucopolysaccharidosis type 1H; Hurler syndrome; MPS I H; Hurler disease; mucopolysaccharidosis type IH; MPSIH
Definition
Hurler syndrome is the most severe form of mucopolysaccharidosis type 1 (MPS1), a rare lysosomal storage disease, characterized by skeletal abnormalities, cognitive impairment, heart disease, respiratory problems, enlarged liver and spleen, characteristic facies and reduced life expectancy.
Disease Hierarchy
DIS6SVEE: Syndromic disease
DISL4MMU: Familial restrictive cardiomyopathy
DISZHA63: Lysosomal storage disease with skeletal involvement
DISTS29G: Mucopolysaccharidosis I
DIS1DPSN: Hurler syndrome
Disease Identifiers
MONDO ID
MONDO_0011758
MESH ID
D008059
UMLS CUI
C0086795
OMIM ID
607014
MedGen ID
39698
HPO ID
HP:0000943
Orphanet ID
93473
SNOMED CT ID
254069004

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
GLB1 TTNGJPH Limited Biomarker [1]
ARSB TTESQTG Strong Genetic Variation [2]
IDS TTNY2AP Strong Biomarker [3]
TTK TTP7EGM Strong Biomarker [4]
PHKG2 TTI5WS6 Definitive Genetic Variation [5]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC26A1 DTJ785O Strong CausalMutation [6]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
IDUA DELTYX6 Strong Autosomal recessive [7]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
IDUA OTTQQ7FN Strong Autosomal recessive [7]
MPEG1 OT7DAO0F Strong Biomarker [4]
RPS27 OTFXKY7P Strong Biomarker [4]
NSUN2 OTZCNM33 Definitive Genetic Variation [5]
------------------------------------------------------------------------------------

References

1 Morquio B patient/caregiver survey: First insight into the natural course of a rare GLB1 related condition.Mol Genet Metab Rep. 2018 Jul 20;16:57-63. doi: 10.1016/j.ymgmr.2018.06.006. eCollection 2018 Sep.
2 Incidence of the mucopolysaccharidoses in Western Australia.Am J Med Genet A. 2003 Dec 15;123A(3):310-3. doi: 10.1002/ajmg.a.20314.
3 Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.Clin Genet. 2016 Dec;90(6):496-508. doi: 10.1111/cge.12795. Epub 2016 May 26.
4 Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1221-1227. doi: 10.1515/jpem-2019-0188.
5 Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet. 2014 Aug;86(2):134-41. doi: 10.1111/cge.12280. Epub 2013 Oct 13.
6 Evaluation and identification of IDUA gene mutations in Turkishpatients with mucopolysaccharidosis type I.Turk J Med Sci. 2016 Feb 17;46(2):404-8. doi: 10.3906/sag-1411-160.
7 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.